6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
5m ago	Yapi ve Kredi Bankasi : Successful issuance of 500 million US$ perpetual Additional Tier 1 Capital Transaction
10m ago	Crown Castle Names Kris Hinson as Chief Commercial Officer and Mark Lennon as Chief Information Officer
15m ago	Hovnanian Enterprises Reports Fiscal 2026 Second Quarter Results
15m ago	LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
15m ago	KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion

About

30.90USD+0.75 +2.49%

Closed • Updated at 13:31 GMT+00:00

Market Cap$2.43B

Volume738.9K

Beta0.82

RSI42.64

Gross Margin-288.80%

Health TechnologyBiotechnology

Celldex Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Celldex Reports First Quarter Financial Results and Provides Corporate Update

Celldex to Present at Upcoming Investor Conference

Celldex Announces Proposed Public Offering of Common Stock

Celldex Announces Pricing of $300 Million Public Offering of Common Stock

Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026

Community Chat

Ask AI